Weiyong Zhao

491 total citations
11 papers, 359 citations indexed

About

Weiyong Zhao is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Weiyong Zhao has authored 11 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cell Biology and 3 papers in Cancer Research. Recurrent topics in Weiyong Zhao's work include Hippo pathway signaling and YAP/TAZ (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Extracellular vesicles in disease (2 papers). Weiyong Zhao is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (3 papers), Nanoplatforms for cancer theranostics (3 papers) and Extracellular vesicles in disease (2 papers). Weiyong Zhao collaborates with scholars based in China. Weiyong Zhao's co-authors include Ke Yang, Jie Xiong, Rubo Cao, Amin Zhang, Shaojun Pan, Daxiang Cui, Mark Huang, Lirui Wang, Qian Zhang and Yuhui Zhang and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and FEBS Letters.

In The Last Decade

Weiyong Zhao

10 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyong Zhao China 6 296 211 57 26 26 11 359
Wenlong Cao China 11 259 0.9× 164 0.8× 52 0.9× 16 0.6× 42 1.6× 20 357
Yuanbing Shen China 9 242 0.8× 205 1.0× 49 0.9× 10 0.4× 45 1.7× 11 356
Muhammed Koçak Türkiye 5 205 0.7× 119 0.6× 28 0.5× 14 0.5× 17 0.7× 7 378
Baofei Jiang China 13 315 1.1× 200 0.9× 37 0.6× 32 1.2× 67 2.6× 20 482
Esther Masiá Spain 9 190 0.6× 158 0.7× 38 0.7× 11 0.4× 36 1.4× 16 322
Benshuai You China 10 257 0.9× 177 0.8× 21 0.4× 16 0.6× 34 1.3× 16 353
Mingwei Chen China 10 219 0.7× 206 1.0× 29 0.5× 16 0.6× 25 1.0× 11 300
Xiaohong Du China 12 237 0.8× 166 0.8× 23 0.4× 23 0.9× 49 1.9× 19 374
Baoxiong Zhuang China 10 324 1.1× 262 1.2× 25 0.4× 11 0.4× 36 1.4× 17 431

Countries citing papers authored by Weiyong Zhao

Since Specialization
Citations

This map shows the geographic impact of Weiyong Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyong Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyong Zhao more than expected).

Fields of papers citing papers by Weiyong Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyong Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyong Zhao. The network helps show where Weiyong Zhao may publish in the future.

Co-authorship network of co-authors of Weiyong Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyong Zhao. A scholar is included among the top collaborators of Weiyong Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyong Zhao. Weiyong Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Chenlu, Zhonghua Cheng, Shuo Gu, et al.. (2024). Cytokine-induced killer cells-mediated chlorin e6-loaded gold nanostars for targeted NIR imaging and immuno-photodynamic combination therapy for lung cancer. Biomedical Materials. 19(4). 45039–45039. 2 indexed citations
2.
Feng, Lei, et al.. (2022). 南翼山富钾锂卤水储层识别方法. Earth Science-Journal of China University of Geosciences. 47(1). 45–45.
3.
Zhang, Qian, Weiyong Zhao, Jin Cheng, et al.. (2021). Heat-induced manganese-doped magnetic nanocarriers combined with Yap-siRNA for MRI/NIR-guided mild photothermal and gene therapy of hepatocellular carcinoma. Chemical Engineering Journal. 426. 130746–130746. 21 indexed citations
4.
Pan, Shaojun, Yuhui Zhang, Mark Huang, et al.. (2021). Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling. Biomaterials. 275. 120946–120946. 92 indexed citations
5.
Yu, Shiyi, Meng Zhang, Ling Huang, et al.. (2019). ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling. Aging. 11(24). 12295–12314. 16 indexed citations
6.
Wang, Haijing, et al.. (2018). Prognostic value of tumor length in predicting survival for patients with esophageal cancer. Translational Cancer Research. 7(3). 506–514. 1 indexed citations
7.
Zhang, Honghong, Weiyong Zhao, Dongying Gu, et al.. (2018). Association of Antioxidative Enzymes Polymorphisms with Efficacy of Platin and Fluorouracil-Based Adjuvant Therapy in Gastric Cancer. Cellular Physiology and Biochemistry. 48(6). 2247–2257. 14 indexed citations
8.
Wang, Haijing, et al.. (2018). Prognostic value of tumor length in predicting survival for patients with esophageal cancer. Translational Cancer Research. 7(3). 506–514. 1 indexed citations
9.
Wen, Juan, Weiyong Zhao, Dongying Gu, et al.. (2017). The prognostic impacts of TEA domain (TEAD) transcription factor polymorphisms in Chinese hepatocellular carcinoma patients. Oncotarget. 8(41). 69823–69832. 2 indexed citations
10.
Yang, Ke, Weiyong Zhao, Jie Xiong, & Rubo Cao. (2013). Downregulation of miR‐16 promotes growth and motility by targeting HDGF in non‐small cell lung cancer cells. FEBS Letters. 587(18). 3153–3157. 83 indexed citations
11.
Yang, Ke, Weiyong Zhao, Jie Xiong, & Rubo Cao. (2013). miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. Biochemistry Research International. 2013. 1–8. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026